Clinical Trials Directory

Trials / Completed

CompletedNCT06501404

PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis

Effects of Probiotic Supplementation During the Neonatal Period on the Preterm Infant

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
583 (actual)
Sponsor
José Antonio Hurtado Suazo · Academic / Other
Sex
All
Age
72 Hours
Healthy volunteers
Accepted

Summary

The main objective of this study is to assess the impact of two different doses of a mixture of probiotics from two strains isolated in human milk on the incidence of severe necrotizing enterocolitis (NEC) and death among preterm infants of gestational age less than or equal to 32 weeks of gestation and weighing between 750 and 1500 g.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHigh dose groupA daily high dose of a mixture of probiotics (Lactobacillus Fermentum CECT 5716 and Bifidobacterium breve CECT 7263), was given orally starting in the first 72 hours of life, until 36+6 weeks of postmenstrual age or discharge The total dose was 1x109 CFU of each of the strains
DIETARY_SUPPLEMENTLow dose groupA daily low dose of a mixture of probiotics (Lactobacillus Fermentum CECT 5716 and Bifidobacterium breve CECT 7263), was given orally starting in the first 72 hours of life, until 36+6 weeks of postmenstrual age or discharge The total dose was 1x106 CFU of each of the strains

Timeline

Start date
2015-01-10
Primary completion
2015-01-15
Completion
2020-03-20
First posted
2024-07-15
Last updated
2024-07-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06501404. Inclusion in this directory is not an endorsement.